Rablip-D

Rablip-D is a synergistic fixed-dose combination of Rabeprazole Sodium, a rapid-acting proton pump inhibitor, and Domperidone (Sustained Release), an effective dopamine antagonist prokinetic. Dual Mechanism: 1. Rabeprazole powerfully shuts down gastric acid pumps to prevent esophageal irritation. 2. Domperidone SR accelerates gastric emptying and increases lower esophageal sphincter tone, preventing reflux and relieving nausea. Indications: • Severe Gastroesophageal Reflux Disease (GERD) accompanied by nausea or vomiting • Non-ulcer dyspepsia and gastric fullness • Diabetic gastroparesis symptoms Dosage: One capsule daily on an empty stomach 30-60 minutes before breakfast.